News

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate ...
RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with ...
Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...
RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with ...
RoosterBio Inc. has partnered with Thermo Fisher Scientific to accelerate the availability of new, potentially life-saving ...
Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...
Home > Press release: Miniature Hearts: Cardiac Organoids With ...
Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...
Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...